RanjithN, MyeniNN, SartoriusB, et al.Association between hyperuricemia and major adverse cardiac events in patients with acute myocardial infarction. Metab Syndr Relat Disord, 2017; 15:18–25.
2.
BoekholdtSM, ArsenaultBJ, MoraS, et al.Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis. JAMA, 2012; 307:1302–1309.
3.
BrattströmLE, IsraelssonB, JeppssonJO, et al.Folic acid—An innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest, 1988; 48:215–221.
4.
VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: A randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol, 2010; 9:855–865.
5.
BostomAG, CarpenterMA, KusekJW, et al.Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the folic acid for vascular outcome reduction in transplantation trial. Circulation, 2011; 123:1763–1770.
6.
PotterK, LenzoN, EikelboomJW, et al.Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: A randomised double-blind, placebo-controlled trial. Cerebrovasc Dis, 2009; 27:259–265.
7.
GreenlandP, KnollMD, StamlerJ, et al.Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA, 2003; 290:891–897.
8.
KhotUN, KhotMB, BajzerCT, et al.Prevalence of conventional risk factors in patients with coronary heart disease. JAMA, 2003; 290:898–904.
9.
KhannaD, FitzgeraldJD, KhannaPP, et al.2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken), 2012; 64:1431–1446.
10.
KhannaD, KhannaPP, FitzgeraldJD, et al.2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken), 2012; 64:1447–1461.
